T-group (topology)

2011.1.1 Zn-dependent exopeptidases

Ligands and drugs

4,844
Member domains
1,670
with ligand contacts (≤ 4 Å)
34.5% of members
1,463
with DrugDomain annotations
30.2% of members
982
with a DrugBank compound
20.3% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 2011.1.1 belongs to X-group 2011 Phosphorylase/hydrolase-like, which binds 8.3 ligand superclasses per 20 proteins, broader than 62% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00141NAGN-Acetylglucosamine144
DB03424BESUbenimex47
DB04489GEMGuanidinoethylmercaptosuccinic acid13
DB07448BEY(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid13
DB00142GLUGlutamic acid9
DB00149LEULeucine9
DB03432BIBBeta-Amino Isobutyrate8
DB03709BCNBicine8
DB03817DABL-2,4-diaminobutyric acid8
DB03590API2,6-Diaminopimelic Acid7
DB04310BB22-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide7
DB00145GLYGlycine6
DB01694TARD-tartaric acid6
DB02386PLULeucine Phosphonic Acid6
DB00139SINSuccinic acid5
DB02652LHYL-[(N-Hydroxyamino)Carbonyl]Phenylalanine5
DB03012CXAPhenylalanine-N-Sulfonamide5
DB03441BIP2-Benzyl-3-Iodopropanoic Acid5
DB04058INGN-Carbamoylphenylalanine5
DB00161VALValine4

Most frequently bound compounds

PDB ligandNameDomains in contact
ZNmetalZINC ION1,322
CAmetalCALCIUM ION190
CLCHLORIDE ION175
NAG2-acetamido-2-deoxy-beta-D-glucopyranose154
MNmetalMANGANESE (II) ION133
NAmetalSODIUM ION78
COmetalCOBALT (II) ION50
BES2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID47
MGmetalMAGNESIUM ION27
KmetalPOTASSIUM ION20
PBD1-(3,4-dimethoxyphenyl)-3-[3-(1H-imidazol-1-yl)propyl]thiourea20
1OT{(R)-amino[4-(1H-pyrazol-1-yl)phenyl]methyl}phosphonic acid12
3MW4-amino-N-{(1R)-2-(hydroxyamino)-2-oxo-1-[4-(1H-pyrazol-1-yl)phenyl]ethyl}benzamide12
4TKN-[(1R)-1-(4-bromophenyl)-2-(hydroxyamino)-2-oxoethyl]-2,2-dimethylpropanamide12
4TLN-[(1R)-2-(hydroxyamino)-2-oxo-1-(3',4',5'-trifluorobiphenyl-4-yl)ethyl]-2,2-dimethylpropanamide12
4TMN-{(1R)-2-(hydroxyamino)-2-oxo-1-[4-(thiophen-3-yl)phenyl]ethyl}-2,2-dimethylpropanamide12
4TYtert-butyl [(1R)-1-(4-bromophenyl)-2-(hydroxyamino)-2-oxoethyl]carbamate12
4U5N-{(1R)-2-(hydroxyamino)-1-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]-2-oxoethyl}-2,2-dimethylpropanamide12
4U6N-{(1R)-2-(hydroxyamino)-1-[3'-(N'-hydroxycarbamimidoyl)biphenyl-4-yl]-2-oxoethyl}-2,2-dimethylpropanamide12
4ZN(2S)-2-{[(R)-[(R)-amino(phenyl)methyl](hydroxy)phosphoryl]methyl}-4-methylpentanoic acid12